The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses
- PMID: 19003369
- PMCID: PMC3449943
- DOI: 10.1023/A:1008021317639
The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses
Abstract
The development of media free of serum and animal or human proteins is of utmost importance for increasing the safety of biologicals produced for therapy and vaccination. In order to reduce the risk of contamination, we have modified the serum free medium MDSS2, a very efficient serum free medium for the production of various biologicals including experimental vaccines using different cell lines (Merten et al., 1994), by replacing the animal derived products by plant extracts. The new serum and animal protein free medium (MDSS2N) can be efficiently used for biomass production of various cell lines. These cells grow equally well or better in this new serum-free medium than in the old formulation (MDSS2):* BHK-21/BRS cells, adapted to MDSS2N, showed an overall specific growth rate of 0.0197 h-1 (mu_max = 0.0510+/-0.0058 h-1), whereas those cultivated in MDSS2 grew with an average specific growth rate of 0.0179 h-1 (mu_max = 0.0305+/-0.0177 h-1).* Vero cells grew with an average specific growth rate of 0.0159 h-1 and 0.0153 h-1 in MDSS2 and MDSS2N, respectively. Very similar growth rates were obtained in microcarrier cultures in stirred tank reactors: the specific growth rates were 0.0161 h-1 and 0.0166 h-1 for MDSS2 and MDSS2N cultures, respectively.* For MDCK cells, when cultured on microcarriers in bioreactors, a higher average specific growth rate was observed in MDSS2N than in MDSS2; values of 0.0248 h-1 and 0.0168 h-1, respectively, were obtained.The capacity of MDSS2N to support the production of different viruses was equally evaluated and it could be established that for certain viruses there are no or insignificant differences between MDSS2N and MDSS2 (influenza and polio virus), whereas, the production of rabies virus is somewhat reduced in MDSS2N when compared to MDSS2. The use of MDSS2N for cell culture and the production of various viruses is discussed.
Similar articles
-
Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines.Cytotechnology. 1994;14(1):47-59. doi: 10.1007/BF00772195. Cytotechnology. 1994. PMID: 7765112
-
An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system.Vaccine. 1995 Sep;13(13):1244-50. doi: 10.1016/0264-410x(94)00022-f. Vaccine. 1995. PMID: 8578811
-
Evaluation of the serum-free medium MDSS2 for the production of poliovirus on vero cells in bioreactors.Cytotechnology. 1997 Nov;25(1-3):35-44. doi: 10.1023/A:1007999313566. Cytotechnology. 1997. PMID: 22358877 Free PMC article.
-
Safety issues of animal products used in serum-free media.Dev Biol Stand. 1999;99:167-80. Dev Biol Stand. 1999. PMID: 10404888 Review.
-
Certain aspects of foot--and--mouth disease. Virus production in growing BHK suspended cell cultures.Dev Biol Stand. 1976;35:55-60. Dev Biol Stand. 1976. PMID: 198314 Review.
Cited by
-
Semliki Forest Virus replicon particles production in serum-free medium BHK-21 cell cultures and their use to express different proteins.Cytotechnology. 2019 Oct;71(5):949-962. doi: 10.1007/s10616-019-00337-y. Epub 2019 Aug 17. Cytotechnology. 2019. PMID: 31422494 Free PMC article.
-
Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium.PLoS One. 2011 Jan 24;6(1):e14578. doi: 10.1371/journal.pone.0014578. PLoS One. 2011. PMID: 21283675 Free PMC article.
-
BHK 21 C13 cells for Aujeszky's disease virus production using the multiple harvest process.Cytotechnology. 2004 Jul;45(3):101-6. doi: 10.1007/s10616-004-2551-z. Cytotechnology. 2004. PMID: 19003247 Free PMC article.
-
Evaluation of recombinant human transferrin (DeltaFerrin(TM)) as an iron chelator in serum-free media for mammalian cell culture.Cytotechnology. 2006 May;51(1):29-37. doi: 10.1007/s10616-006-9011-x. Epub 2006 Aug 3. Cytotechnology. 2006. PMID: 19002892 Free PMC article.
-
Production of Oncolytic Measles Virus in Vero Cells: Impact of Culture Medium and Multiplicity of Infection.Viruses. 2024 Nov 6;16(11):1740. doi: 10.3390/v16111740. Viruses. 2024. PMID: 39599854 Free PMC article.
References
-
- Brands R, van Scharrenburg GJM, Palache AM. Production of influenza virus in cell cultures for vaccine preparation. In: Carrondo MJT, Griffiths B, Moreira J, editors. Animal Cell Technology: From Vaccines to Genetic Medicine. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1997. pp. 165–167.
-
- Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/PharmacyWorking Party on Safety Medicines EEC Regulatory Document, Note for Guidance. Guidelines for minimizing the risk of transmitting agents causing spongiform encephalopathy via medicinal products. Biologicals. 1992;20:155–158. doi: 10.1016/S1045-1056(05)80063-6. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials